Anifrolumab, a relatively recent monoclonal antigen, is generating considerable interest within the healthcare community as a viable option for various immune-related conditions. This unique drug targets the immune https://bookmark-template.com/story28715632/anifrolumab-a-novel-approach-for-autoimmune-conditions